Online registration for the 8th CAR-TCR Summit is now closed. If you would like to register your interest for the 2024 event, please click below.
Explore Related Cell Therapy Products
Delivering Safer, More Effective & Globally Accessible Cell Therapies to Patients at Scale
Beacon's cell therapy database covers trial and drug records for preclinical, active, approved, and discontinued CAR (chimeric antigen receptor) modified therapies, TCR (T-Cell Receptor) therapies, natural killer cells, tumor-infiltrating lymphocytes cytokine-induced killer cells, dendritic cells, and macrophages.
A year-round experience-sharing and problem-solving network helping drug developers address critical R&D challenges in CAR-TCR therapies for solid tumors.
A trusted provider of market intelligence for anyone looking to understand the complexities of cell therapy research and development.